HBM HEALTHCARE INVESTMENTS AG

As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging companies in the biotechnology/human medicine, diagnostics and medical technology sectors. The primary products of HBM BioVentures' portfolio companies are either at an advanced stage of development or already available on the market. The company focuses on unquoted emerging companies, with two-thirds are invested in private companies that offer high value creation potential. This has enabled HBM BioVentures to carve out a unique and distinctive market position. HBM BioVentures has a broad shareholder base and is listed on the SIX Swiss Exchange (ticker: HBMN).
HBM HEALTHCARE INVESTMENTS AG
Industry:
Biotechnology Finance Financial Services Health Care Medical Venture Capital
Founded:
2001-07-12
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager Google Universal Analytics Global Site Tag Nginx
Similar Organizations
CRCM Ventures
CRCM Ventures invests in early stage companies, targeting consumer, climate tech, frontier tech, health, and fintech industries.
Felix Capital
Felix Capital is a venture fund that focuses on digital commerce, digital media, and information technology companies.
Longitude Capital
Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.
MassMutual Ventures
MMV is a multi-stage, global venture capital firm investing in enterprise software, cybersecurity, financial technology, and digital health.
MMC Ventures
MMC Ventures is an investment firm that invests in technology companies at Seed and Series A.
New Enterprise Associates
New Enterprise Associates is a global venture capital firm investing in technology and healthcare.
XAnge
XAnge is a Franco-German team of venture capital investors that manages assets and invests in digital, deeptech, and impact startups.
Current Advisors List
Current Employees Featured
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2003-02-04 | New Medical Technologies | New Medical Technologies acquired by HBM Healthcare Investments AG | N/A |
Investments List
Date | Company | Article | Money raised |
---|---|---|---|
2022-09-06 | 1mg | HBM Healthcare Investments AG investment in Venture Round - 1mg | 3.19 B INR |
2022-07-12 | Vascular Dynamics | HBM Healthcare Investments AG investment in Venture Round - Vascular Dynamics | 20 M USD |
2022-06-14 | Dren Bio | HBM Healthcare Investments AG investment in Series B - Dren Bio | 65 M USD |
2022-06-08 | Mineralys Therapeutics | HBM Healthcare Investments AG investment in Series B - Mineralys Therapeutics | 118 M USD |
2022-06-02 | Upstream Bio | HBM Healthcare Investments AG investment in Series A - Upstream Bio | 200 M USD |
2022-03-28 | Aculys Pharma | HBM Healthcare Investments AG investment in Series B - Aculys Pharma | 2.8 B JPY |
2022-03-07 | Karius | HBM Healthcare Investments AG investment in Series B - Karius | N/A |
2022-02-07 | 1000Farmacie | HBM Healthcare Investments AG investment in Series A - 1000Farmacie | 15 M USD |
2022-01-18 | Mineralys Therapeutics | HBM Healthcare Investments AG investment in Series A - Mineralys Therapeutics | N/A |
2022-01-04 | Adrenomed | HBM Healthcare Investments AG investment in Convertible Note - Adrenomed | N/A |
More informations about "HBM Healthcare Investments AG"
HBM Healthcare Investments - Wikipedia
HBM Healthcare Investments is a publicly traded (HBMN:SW) Swiss investment and venture capital firm focusing on emerging technologies in the global healthcare sector. Within healthcare their focus is predominantly in biotechnology, medical technology, diagnostics, therapeutics and digital health. A 2022 article in Swiss daily Luzerner Zeitung profiled HBM and interviewed itโฆSee details»
Homepage | HBM Healthcare
Dec 15, 2024 HBM Healthcare Investments AG. SIX Swiss Exchange: 12/30/2024 17:30 ... HBM Healthcare Investments publishes Half-Year Report as at 30 September 2024 with key figures โฆSee details»
HBM Healthcare Investments - Crunchbase
HBM Healthcare Investments focuses on early to late-stage investments in biotechnology, healthcare, and pharmaceutical industries, with a geographical focus on the United States and โฆSee details»
Investors - HBM Healthcare
5 days ago Net Asset Value (NAV) per share (in CHF) as at 15 December 2024: 245.18: as at 30 November 2024: 250.56: as at 15 November 2024: 251.81See details»
Company Fact Sheet HBM November 2021 - HBM Healthcare
HBM Healthcare Investments Company Fact Sheet November 2021 (Data as of 31 October 2021) Unique investments in private and listed life science companies 1 Swiss investment company โฆSee details»
HBM Healthcare Investments AG, HBMN:SWX profile - FT.com
6 days ago HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, โฆSee details»
HBM Healthcare Investments - Investments, Portfolio & Company โฆ
HBM Healthcare Investments 's most notable exits include IO Biotech, Seer, and Everest Medicines. HBM Healthcare Investments has acquired New Medical Technologies on Feb 4, โฆSee details»
HBM Healthcare Investments AG (CH001262) | HBM Healthcare โฆ
1 day ago The relevant healthcare sector market indices, measured in Swiss francs, also performed positively, but all lagged behind HBM Healthcare Investments (MSCI World Health โฆSee details»
HBM Healthcare Investments AG, HBMN:SWX summary - FT.com
Dec 27, 2024 As of last trade, HBM Healthcare Investments AG (HBMN:SWX) traded at 177.80, 14.71% above the 52 week low of 155.00 set on Feb 12, 2024. 52-week range. Today. 155.00 โฆSee details»
Company HBM Healthcare Investments AG - MarketScreener.com
Dec 31, 2002 HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, โฆSee details»
HBM Healthcare Investments AG (LON: 0QOC) - Stock Analysis
Dec 27, 2024 HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, โฆSee details»
Key Figures 31.12.2024 - BörsenNEWS.de
1 day ago Wenn Sie keine Mitteilungen von HBM Healthcare Investments mehr wünschen, ... HBM Healthcare Investments AG: Bundesplatz 1: 6300 Zug: Switzerland: Phone: โฆSee details»
HBM Healthcare renoue avec les bénéfices sur neuf mois
1 day ago HBM Healthcare Investments AG est une société de capital-risque basée en Suisse qui investit dans des entreprises émergentes, principalement dans les secteurs de la โฆSee details»
HBM Healthcare Investments AG: Key Figures 31.12.2024
1 day ago HBM Healthcare Investments AG Bundesplatz 1 CH-6300 Zug - Switzerland Tel. +41 41 710 75 77 [email protected] hbmhealthcare.com Wenn Sie keine Mitteilungen von โฆSee details»
HBM Healthcare Investments reports a compelling 15 percent
2 days ago HBM Healthcare Investments AG / Key word(s): Quarter Results HBM Healthcare Investments reports a compelling 15 percent increase in NAV in the 2024 calendar year 03 โฆSee details»
HBM HEALTHCARE INVESTMENTS AG
1 day ago HBM Healthcare Investments AG is a Switzerland-based venture capital company investing in emerging companies, mainly from the biotechnology and human medicine, โฆSee details»
HBM Healthcare Investments
HBM Healthcare Investments UNIQUE INVESTMENTS IN PRIVATE AND LISTED LIFE SCIENCE COMPANIES JULY 2021. HBM HEALTHCARE INVESTMENTS ... Source: โฆSee details»
HBM Healthcare Investments AG
1 day ago HBM Healthcare Investments AG / Key word(s): Monthly Figures Key Figures 31.12.2024 03.01.2025 / 17:47 CET/CEST in CHF ... Wenn Sie keine Mitteilungen von HBM โฆSee details»
HBM Healthcare Investments AG (CH001262) | Key Figures โฆ
1 day ago HBM Healthcare Investments AG releases key financial figures for 31.12.2024, showing performance in CHF. NAV at 251.17 CHF and Share Price at 176.00 CHF. Basculer โฆSee details»
HBM Healthcare Investments reports a compelling 15 percent โฆ
1 day ago HBM Healthcare Investments closed the calendar year 2024 with a strong performance. Its net asset value (NAV) per share rose by 15 percent to CHF 251.17.See details»